These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


525 related items for PubMed ID: 18928510

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Early onset multiple alloimmunization (anti-E and anti-Jkb) in a thalassaemic.
    Thakral B, Saluja K, Sharma RR, Marwaha N, Marwaha RK.
    Clin Lab Haematol; 2006 Aug; 28(4):286-7. PubMed ID: 16898974
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Irregular erythrocytic antibodies as an obstacle to transfusion].
    Uhlig R, Endert G, Lammel G.
    Z Arztl Fortbild (Jena); 1984 Aug; 78(20):849-52. PubMed ID: 6523909
    [No Abstract] [Full Text] [Related]

  • 7. Evaluating the clinical significance of blood group alloantibodies that are causing problems in pretransfusion testing.
    Garratty G.
    Vox Sang; 1998 Aug; 74 Suppl 2():285-90. PubMed ID: 9704458
    [No Abstract] [Full Text] [Related]

  • 8. The risk of an overt hemolytic transfusion reaction following the use of an immediate spin crossmatch.
    Shulman IA.
    Arch Pathol Lab Med; 1990 Apr; 114(4):412-4. PubMed ID: 2322101
    [Abstract] [Full Text] [Related]

  • 9. Allosensitization in patients receiving multiple blood transfusions.
    Sakhalkar VS, Roberts K, Hawthorne LM, McCaskill DM, Veillon DM, Caldito GC, Cotelingam JD.
    Ann N Y Acad Sci; 2005 Apr; 1054():495-9. PubMed ID: 16339705
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Ok(a) antigen and anti-Ok(a) antibody].
    Okubo M.
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():780-1. PubMed ID: 20942188
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Blood and blood product transfusions. Immunological basis and indications].
    Andreu G.
    Rev Prat; 2001 Feb 15; 51(3):299-305. PubMed ID: 11265428
    [No Abstract] [Full Text] [Related]

  • 17. Red cell exchange does not appear to increase the rate of allo- and auto-immunization in chronically transfused children with sickle cell disease.
    Venkateswaran L, Teruya J, Bustillos C, Mahoney D, Mueller BU.
    Pediatr Blood Cancer; 2011 Aug 15; 57(2):294-6. PubMed ID: 21298771
    [Abstract] [Full Text] [Related]

  • 18. [Current problems of blood transfusion. Responsibility of the physician in transfusion].
    Schönitzer D, Rosmanith P, Kilga-Nogler S.
    Infusionsther Klin Ernahr; 1985 Aug 15; 12(4):170-4. PubMed ID: 4066002
    [Abstract] [Full Text] [Related]

  • 19. Do you think that the cross match with donor red cells can be omitted when the serum of a patient has been tested for the presence of red cell alloantibodies with a cell panel?
    Vox Sang; 1982 Aug 15; 43(3):151-68. PubMed ID: 6815895
    [No Abstract] [Full Text] [Related]

  • 20. Alloimmunization to red blood cell antigens after universal leucodepletion. A regional multicentre retrospective study.
    Schonewille H, Brand A.
    Br J Haematol; 2005 Apr 15; 129(1):151-6. PubMed ID: 15801967
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 27.